STOCK TITAN

Notifications

Limited Time Offer! Get Platinum at the Gold price until January 31, 2026!

Sign up now and unlock all premium features at an incredible discount.

Read more on the Pricing page

Radnet Stock Price, News & Analysis

RDNT Nasdaq

Welcome to our dedicated page for Radnet news (Ticker: RDNT), a resource for investors and traders seeking the latest updates and insights on Radnet stock.

RadNet Inc (NASDAQ: RDNT) operates one of the largest networks of outpatient diagnostic imaging centers in the U.S., combining advanced medical imaging services with AI-powered health informatics solutions. This news hub provides investors and healthcare professionals with essential updates on the company's financial performance, technological advancements, and strategic initiatives.

Access authoritative reporting on quarterly earnings, partnership announcements, and innovations in radiology workflow optimization. Our curated collection features official press releases alongside third-party analysis of RadNet's Imaging Center operations and DeepHealth digital solutions.

Key updates include developments in AI-enhanced diagnostic tools, imaging center expansions, and regulatory milestones. Track how RDNT integrates cloud-native platforms with traditional radiology services to improve patient outcomes and operational efficiency.

Bookmark this page for continuous access to verified information about RadNet's market position. Check regularly for updates on service enhancements, financial disclosures, and leadership insights shaping the future of diagnostic imaging.

Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) announced that CEO Howard Berger will participate in the Cancer Moonshot Goals Forum, aimed at reducing cancer mortality by 50% over 25 years. The White House has invited RadNet, a leader in outpatient diagnostic imaging, to leverage its expertise in cancer screening and artificial intelligence. Currently performing 5% of mammograms nationally, RadNet plans to expand its AI-driven tools for detecting other cancers. Dr. Berger emphasized the importance of early detection for improving cancer outcomes and called for collaboration to drive substantial changes in care.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.59%
Tags
conferences
-
Rhea-AI Summary

RadNet reported an 8.4% increase in revenue to $341.8 million for Q1 2022 compared to Q1 2021. Excluding AI revenue, the Imaging Center segment saw an 8.2% rise to $341.2 million. Adjusted EBITDA for Imaging Centers increased 4.1% to $41.7 million. However, net income dropped to $3.0 million from $9.5 million, and diluted EPS fell to $0.05. Despite a projected loss from new AI investments, RadNet has revised its 2022 revenue guidance upward to between $1.36 billion and $1.41 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
-
Rhea-AI Summary

RadNet (NASDAQ: RDNT) announced that Mark Stolper, Executive Vice President and Chief Financial Officer, will present at the Bank of America Securities 2022 Health Care Conference. The event is scheduled for May 11, 2022, at 10:00 a.m. Pacific Time, held at the Encore Hotel in Las Vegas, NV. The presentation will also be available via simultaneous and archived webcasts. RadNet is recognized as a national leader in diagnostic imaging services, operating 347 outpatient imaging centers across several states, employing approximately 9,000 individuals.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.42%
Tags
conferences
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) will host a conference call on May 9, 2022, at 7:30 a.m. PT to discuss its Q1 2022 financial results. Investors can participate by calling 888-204-4368 (U.S.) or 929-477-0402 (international). The company operates a network of 347 outpatient imaging centers across several states, including California and New York, employing approximately 9,000 individuals. RadNet is a leader in the U.S. diagnostic imaging market, focusing on high-quality, cost-effective services.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.77%
Tags
conferences earnings
-
Rhea-AI Summary

RadNet, a leader in diagnostic imaging services, announced that CFO Mark Stolper will speak at the Sidoti & Company Spring 2022 Conference on March 24, 2022, at 01:00 p.m. ET. The event will include a live and archived webcast, accessible via RadNet's website and the conference link provided. RadNet operates 347 imaging centers across various U.S. states and employs around 9,000 individuals. The company specializes in high-quality, cost-effective imaging solutions, with a focus on technology integration, including artificial intelligence.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.84%
Tags
conferences
-
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) reported a revenue increase of 8.0% in Q4 2021, totaling $333.2 million, despite facing challenges from the Omicron COVID-19 surge, which impacted revenue by over $4 million. Adjusted EBITDA rose 7.5% to $54.5 million. Adjusted EPS was $0.13, down from $0.20 in Q4 2020, primarily due to increased expenses. The company ended 2021 with a cash balance of $134.6 million and a Net Leverage Ratio of 2.9x. For 2022, RadNet anticipates growth in revenue and adjusted EBITDA, despite potential losses from its AI ventures.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.13%
Tags
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) will host a conference call on March 1, 2022, at 7:30 a.m. PT to discuss its fourth-quarter 2021 financial results. Investors can participate by dialing 888-254-3590 for the U.S. or 929-477-0402 for international calls. An archived webcast will also be available. RadNet operates a network of 350 outpatient imaging centers across multiple states, making it a leading provider of diagnostic imaging services in the U.S., with approximately 9,000 employees and significant annual imaging revenue.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.22%
Tags
conferences earnings
-
Rhea-AI Summary

RadNet, Inc. (NASDAQ: RDNT) has acquired two Dutch AI companies, Aidence and Quantib, enhancing its cancer screening capabilities. Aidence specializes in lung cancer detection and has products pending FDA approval, while Quantib offers solutions for prostate and brain MRI with existing FDA clearances. These acquisitions aim to bolster RadNet's AI division, focusing on comprehensive cancer screening for breast, prostate, and lung cancers. Dr. Gregory Sorensen will oversee AI initiatives, aiming to leverage RadNet's extensive imaging database for improved patient outcomes.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.61%
Tags
-
Rhea-AI Summary

eRAD, a RadNet subsidiary, announced the successful deployment of its comprehensive radiology solutions at Advanced Imaging Concepts (AIC) in Florida. This integration includes eRAD RIS, PACS, Speech Recognition, and more, aimed at enhancing workflows and increasing efficiencies. AIC reported significant improvements in scheduling and check-in processes, empowering staff to handle more procedures without additional hires. The eRAD team ensured seamless implementation, providing extensive training. AIC's management expressed satisfaction with the partnership, highlighting the effectiveness of customized workflows.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.82%
Tags
none
Rhea-AI Summary

RadNet, a leader in diagnostic imaging, announced that Mark Stolper, CFO, will present at the Jefferies 2021 London Healthcare Conference from November 16-19, 2021. The presentation will be available on-demand starting at 8:00 a.m. GMT (12 AM Pacific) on November 18, 2021. RadNet operates a network of 350 outpatient imaging centers across several states, employing approximately 8,300 staff members. The event can be accessed via webcast and will be archived for 30 days afterwards.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.89%
Tags
conferences

FAQ

What is the current stock price of Radnet (RDNT)?

The current stock price of Radnet (RDNT) is $78.31 as of November 7, 2025.

What is the market cap of Radnet (RDNT)?

The market cap of Radnet (RDNT) is approximately 6.1B.
Radnet

Nasdaq:RDNT

RDNT Rankings

RDNT Stock Data

6.08B
67.13M
12.73%
94.2%
7.83%
Diagnostics & Research
Services-medical Laboratories
Link
United States
LOS ANGELES